Spectrocon LLC has developed an innovative medical device to treat postsurgical venous congestion. SpectroCon develops and commercializes AutoFlow, a medical device for the treatment of a serious complication of reconstructive surgery known as venous congestion. Currently, SpectroCon is focusing 100% of its efforts on the development of breakthrough technology and has no commercially available products or sales. The SpectroCon team has significant knowledge and expertise in the areas of vascular physiology, reconstructive microsurgery, and business administration. In our partnership with the Wisconsin Alumni Research Foundation (WARF), we have a patent pending on our blood removal technology. We are dedicated to providing patients with an effective alternative to postsurgical leech therapy that is geared toward restoration of tissue function
